Growth Metrics

Biogen (BIIB) Depreciation and Depletion (2018 - 2026)

Biogen has reported Depreciation and Depletion over the past 9 years, most recently at $67.9 million for Q1 2026.

  • For Q1 2026, Depreciation and Depletion fell 4.9% year-over-year to $67.9 million; the TTM value through Mar 2026 reached $269.3 million, down 6.75%, while the annual FY2025 figure was $272.8 million, 4.85% down from the prior year.
  • Depreciation and Depletion for Q1 2026 was $67.9 million at Biogen, roughly flat from $68.0 million in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $76.3 million in Q1 2022 and troughed at $62.1 million in Q1 2023.
  • A 5-year average of $67.9 million and a median of $67.2 million in 2022 define the central range for Depreciation and Depletion.
  • Biggest five-year swings in Depreciation and Depletion: surged 56.35% in 2022 and later decreased 18.61% in 2023.
  • Year by year, Depreciation and Depletion stood at $64.7 million in 2022, then fell by 1.85% to $63.5 million in 2023, then rose by 14.65% to $72.8 million in 2024, then fell by 6.59% to $68.0 million in 2025, then fell by 0.15% to $67.9 million in 2026.
  • Business Quant data shows Depreciation and Depletion for BIIB at $67.9 million in Q1 2026, $68.0 million in Q4 2025, and $66.5 million in Q3 2025.